HK Stock Announcement Highlights | SOFTCARE to List Tomorrow; FIH Expects Significant Improvement in Annual Financial Performance

Stock News

Nov 09

**Key Updates** - **SOFTCARE (02698)**: Hong Kong public offering oversubscribed by 1,813.77 times, expected to list on November 10. - **HENGRUI PHARMA (01276)**: HRS-2430 and SHR-4610 injections receive clinical trial approval notices. - **LEADS BIOLABS-B (09887)**: Included in the MSCI Global Small Cap Index.

**Financial Data** - **FIH (02038)**: Anticipates annual revenue growth of approximately 15% and significant improvement in financial performance. - **BOYAA (00434)**: Expects attributable profit growth of 105%–115% YoY for the first nine months.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/1199117456"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1199117456\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1199117456?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-09 20:04","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1199117456","market":"sh","top_or_hot":-1,"title":"HK Stock Announcement Highlights | SOFTCARE to List Tomorrow; FIH Expects Significant Improvement in Annual Financial Performance","media":"Stock News","content":"<p>**Key Updates**  \n- **SOFTCARE (02698)**: Hong Kong public offering oversubscribed by 1,813.77 times, expected to list on November 10.  \n- **HENGRUI PHARMA (01276)**: HRS-2430 and SHR-4610 injections receive clinical trial approval notices.  \n- **LEADS BIOLABS-B (09887)**: Included in the MSCI Global Small Cap Index.</p>\n<p>**Financial Data**  \n- **FIH (02038)**: Anticipates annual revenue growth of approximately 15% and significant improvement in financial performance.  \n- **BOYAA (00434)**: Expects attributable profit growth of 105%–115% YoY for the first nine months.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>HK Stock Announcement Highlights | SOFTCARE to List Tomorrow; FIH Expects Significant Improvement in Annual Financial Performance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHK Stock Announcement Highlights | SOFTCARE to List Tomorrow; FIH Expects Significant Improvement in Annual Financial Performance\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2025-11-09 20:04</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>**Key Updates**  \n- **SOFTCARE (02698)**: Hong Kong public offering oversubscribed by 1,813.77 times, expected to list on November 10.  \n- **HENGRUI PHARMA (01276)**: HRS-2430 and SHR-4610 injections receive clinical trial approval notices.  \n- **LEADS BIOLABS-B (09887)**: Included in the MSCI Global Small Cap Index.</p>\n<p>**Financial Data**  \n- **FIH (02038)**: Anticipates annual revenue growth of approximately 15% and significant improvement in financial performance.  \n- **BOYAA (00434)**: Expects attributable profit growth of 105%–115% YoY for the first nine months.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1191","symbol_name":"制药","start_time":0,"source_url":"","article_id":"1199117456","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1199117456","pubTimestamp":1762689852,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"**Key Updates**   - **SOFTCARE (02698)**: Hong Kong public offering oversubscribed by 1,813.77 times, expected to list on November 10.   - **HENGRUI PHARMA (01276)**: HRS-2430 and SHR-4610 injections...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1191":"制药","BK1526":"科网股","BK1161":"生物科技","09887":"维立志博-B","BK1104":"互动家庭娱乐","BK1160":"纺织品","LU0359201885.HKD":"BGF CHINA \"A2\" (HKD) ACC","BK1612":"加密货币概念","BK1508":"富士康概念","01276":"恒瑞医药","02038":"富智康集团","LU0359201612.USD":"贝莱德中国基金A2","BK1167":"电子制造服务","LU0359202008.SGD":"Blackrock China Fund A2 SGD-H","BK1531":"手游股","LU1023057109.AUD":"BGF CHINA \"A2\" (AUDHDG) ACC","02698":"乐舒适","BK1504":"苹果概念","00434":"博雅互动","LU2543165471.USD":"E FUND (HK) GLOBAL QUALITY GROWTH \"A\" (USD) ACC"},"translate_title":"港股公告集锦|SOFTCARE明日上市；富智康预计年度财务业绩将大幅改善","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00434":1,"01276":1,"02038":1,"02698":1,"09887":1},"content_text":"**Key Updates**  \n- **SOFTCARE (02698)**: Hong Kong public offering oversubscribed by 1,813.77 times, expected to list on November 10.  \n- **HENGRUI PHARMA (01276)**: HRS-2430 and SHR-4610 injections receive clinical trial approval notices.  \n- **LEADS BIOLABS-B (09887)**: Included in the MSCI Global Small Cap Index.\n**Financial Data**  \n- **FIH (02038)**: Anticipates annual revenue growth of approximately 15% and significant improvement in financial performance.  \n- **BOYAA (00434)**: Expects attributable profit growth of 105%–115% YoY for the first nine months.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}